Previous research investigating the role of the plasminogen activation system on cancer progression has measured uPAR expression on excised tumor tissue, blood levels of urokinase-type plasminogen activator (uPA), and the various forms of uPAR and suPAR in circulation. This evidence concerns the gene PLAU and cancer.